US Patent 7825127 Method for treating cancer
Patent 7825127 was granted and assigned to Takeda Pharmaceutical Company on November, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+212 characters)
Article
Patent abstract
The present invention provides a method for treating cancer, which includes selecting a patient coexpressing HER2 and HER3, and administering an effective amount of a HER2 inhibitor to the patient.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Shinji Takagi0
Yoshikazu Ohta0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07825127 Method for treating cancer US Patent 7825127 Method for treating cancer
Infobox
Patent Number
07825127
Patent Number
7825127
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07825127 Method for treating cancer
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07825127
Date of patent
November 2, 2010
Patent application number
12005883
Date Filed
December 27, 2007
Patent primary examiner
Find more entities like US Patent 7825127 Method for treating cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.